Oleander Medical Technologies
oleandermed.comOleander Medical Technologies is an American company developing targeted osmotic lysis (TOL), an investigational cancer treatment combining digoxin with a pulsed electric field device.
This record contains identity and selected historical facts. Business areas, products and practical answers have not been added.
Data formats & record details
Data access & reuse
- Wikidata data accessWikidata · 2026-11-16
- Wikidata reuse permissionWikidata · 2026-11-16
- CC0 1.0 UniversalWikidata · 2026-11-16
- Entity ID
- urn:readyscan:entity:oleander-medical-technologies-q141774570
- Material fingerprint
- fnv1a64:f7423b4d1549c937
- Entity revision
- fnv1a64:4fb32c2f2959638b
- Published
- 2026-11-16
- Modified
- 2026-11-16
- Source summary
- Oleander Medical Technologies: American company developing targeted osmotic lysis (TOL), an investigational cancer treatment combining digoxin with a pulsed electric field device. Website: https://oleandermed.com/
- Evidence record
- urn:readyscan:corpus:evidence:oleander-medical-technologies-q141774570